Industry Outlook
Breast biopsy procedure refers to extraction of tissue sample from the breast for examination and diagnosis. Due to the advantage of least disfigurement and pain, physicians are increasingly performing minimally invasive biopsy procedures. Therefore, the prime factors that support the market growth of breast biopsy devices are increasing incidence of breast cancer, growing awareness about cancer screening programs and advancing preference for minimally invasive procedures and dedicated systems. Perpetual technological advances in diagnostics and treatment methods for breast cancer have facilitated the introduction of minimally invasive procedures, thereby improving the treatment outcome rate. Breast cancer is among the most common cancer types in women worldwide, and growing awareness has thereby facilitated high demand for advanced diagnostic techniques. However risk of infections and affordability issues may hold back the growth of this market.
Market Synopsis
Vacuum Assisted Breast Biopsy Technology to Spearhead the Global Market
Conventionally, open surgical breast biopsies were the gold standard for sample extraction. However, with the advent of fine needle aspiration, the clinical scenario underwent transition and minimally invasive procedures witnessed significant growth in demand. However, drawbacks of fine needle aspiration procedures such as compromised accuracy in determining PR, ER and Her-2 status, high risk of negative results and dearth of standard interpretation guidelines led to replacement of this technique by further advanced procedures such as vacuum assisted breast biopsy and core needle biopsy. Currently, the global breast biopsy devices market is dominated by widespread acceptance of vacuum assisted breast biopsy procedure and as it conveniently overcome the drawbacks of conventional methods.
Uptake of Guidance Systems to Remain Steady through the Forecast Period
In the base year 2017, the global breast biopsy devices market witnessed biopsy guidance systems to have the largest revenue share. The segment will continue to dominate the overall market through the forecast period. Long equipment life, established clinical evidence on efficacy and moderate equipment cost are the major factors that are contributing to the prime position of biopsy guidance systems segment. The share of this segment will be cannibalized by the growing uptake of biopsy needles during the forecast period. Faster uptake of these products and growing demand for disposable needles in both developed and developing markets contribute to the faster growth rate of this segment.
Upswing in Adoption of MRI Guidance Modality to Boost the Market Growth
Currently, stereotactic x-ray guided biopsy systems enjoy dominance in the overall breast biopsy devices market. This modality since its introduction had gradually replaced the conventional open surgical biopsies. This modality is often viewed as cost effective and has been adopted worldwide. However, the dominance of stereotactic x-ray guided biopsy is critically challenged by the growing uptake of MRI guided biopsy. MRI guided biopsy is being widely adopted in developed markets of North America and Europe on the ground of better precision and greater awareness in paints and physicians.
Asia Pacific Set to Cannibalize on Market Shares of North America and Europe
Breast biopsy devices find wide usage in not just cancer diagnosis, but also in disease progress and treatment outcome monitoring. At present North America is the largest regional market for breast biopsy devices due to complete replacement of open surgical biopsy procedures with the minimally invasive counterparts. Additionally, better reimbursements to the latest and advanced biopsy modalities are also attributed to the dominance of North America market. However the North America market will lose significant market share to the rapidly advancing Asia Pacific market during the forecast period. Fast evolution of healthcare infrastructure, growing replacement of stereotactic X-ray biopsy systems with MRI guided systems and growing base of breast cancer patients are the key drivers of Asia Pacific breast cancer devices market. Additionally, swift progress of medical tourism in the region will also open further market penetration opportunities for manufacturers.
Historical & Forecast Period
2016 – Historical Year
2017 – Base Year
2018-2026 – Forecast Period
This research report presents the analysis of each considered segment for the period from 2016 to 2026, having 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
The breast biopsy devices market report provides quantitative assessment of the industry terms of current and forecasted market size, while also presenting the market dynamics. This market is segmented based on products, biopsy type, guidance modality, and geography.
By Biopsy Type (2016–2026; US$ Mn)
By Product (2016–2026; US$ Mn)
By Guidance Modality (2016–2026; US$ Mn)
Geography Segment (2016–2026; US$ Mn)
The current market dynamics in the breast biopsy devices industry are studied in the market overview section of the report where the drivers, challenges and future prospects in the market are scrutinized. This section also includes graphical presentation of the competitive landscape currently prevalent in the global breast biopsy devices market. Major players operating in the global breast biopsy devices market are studied based on their business overview, product portfolio, financial information and key developments. Hologic, Becton, Dickinson and Company, C.R. Bard, Inc., Mammotome (Devicor Medical Products, Inc.), Aurora Imaging Technology, Inc., and Planmed OY are the prime market players considered in this sevtion.
Key questions answered in this report
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Breast Biopsy Devices Market Portraiture
2.2. Global Breast Biopsy Devices Market, by Biopsy Type, 2017 (US$ Mn)
2.3. Global Breast Biopsy Devices Market, by Product, 2017 (US$ Mn)
2.4. Global Breast Biopsy Devices Market, by Guidance Modality, 2017 (US$ Mn)
2.5. Global Breast Biopsy Devices Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Breast Biopsy Devices Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Breast Biopsy Devices Market, by Key Players, 2017
Chapter 4. Global Breast Biopsy Devices Market, by Biopsy Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Fine Needle Aspiration Biopsy (FNAB)
4.3. Core Needle Biopsy (CNB)
4.4. Vacuum Assisted Breast Biopsy (VABB)
4.5. Incisional and Excisional Breast Biopsy
Chapter 5. Global Breast Biopsy Devices Market, by Product, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Needle Based Biopsy Guns
5.3. Biopsy Guidance Systems
5.4. Biopsy Forceps
5.5. Biopsy Needles
5.6. Others (Curettes, Punches, Markers)
Chapter 6. Global Breast Biopsy Devices Market, by Guidance Modality, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Stereotactic X-ray Guided Biopsy
6.3. Ultrasound Guided Biopsy
6.4. MRI Guided Biopsy
6.5. Without Imaging Guidance Biopsy
Chapter 7. Global Breast Biopsy Devices Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.1.1. North America Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
7.1.2. North America Breast Biopsy Devices Market, by Biopsy Type, 2016 - 2026 (US$ Mn)
7.1.3. North America Breast Biopsy Devices Market, by Product, 2016 - 2026 (US$ Mn)
7.1.4. North America Breast Biopsy Devices Market, by Guidance Modality, 2016 - 2026 (US$ Mn)
North America Breast Biopsy Devices Market, by Country, 2016 – 2026 (US$ Mn)
7.1.4.1. U.S.
7.1.4.2. Canada
7.2. Europe Breast Biopsy Devices Market, 2016 – 2026 (US$ Mn)
7.2.1. Europe Breast Biopsy Devices Market, by Biopsy Type, 2016 - 2026 (US$ Mn)
7.2.2. Europe Breast Biopsy Devices Market, by Product, 2016 - 2026 (US$ Mn)
7.2.3. Europe Breast Biopsy Devices Market, by Guidance Modality, 2016 - 2026 (US$ Mn)
7.2.4. Europe Breast Biopsy Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific Breast Biopsy Devices Market, 2016 – 2026 (US$ Mn)
7.3.1. Asia Pacific Breast Biopsy Devices Market, by Biopsy Type, 2016 - 2026 (US$ Mn)
7.3.2. Asia Pacific Breast Biopsy Devices Market, by Product, 2016 - 2026 (US$ Mn)
7.3.3. Asia Pacific Breast Biopsy Devices Market, by Guidance Modality, 2016 - 2026 (US$ Mn)
7.3.4. Asia Pacific Breast Biopsy Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America Breast Biopsy Devices Market, 2016 – 2026 (US$ Mn)
7.4.1. Latin America Breast Biopsy Devices Market, by Biopsy Type, 2016 - 2026 (US$ Mn)
7.4.2. Latin America Breast Biopsy Devices Market, by Product, 2016 - 2026 (US$ Mn)
7.4.3. Latin America Breast Biopsy Devices Market, by Guidance Modality, 2016 - 2026 (US$ Mn)
7.4.4. Latin America Breast Biopsy Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa Breast Biopsy Devices Market, 2016 – 2026 (US$ Mn)
7.5.1. Middle East & Africa Breast Biopsy Devices Market, by Biopsy Type, 2016 - 2026 (US$ Mn)
7.5.2. Middle East & Africa Breast Biopsy Devices Market, by Product, 2016 - 2026 (US$ Mn)
7.5.3. Middle East & Africa Breast Biopsy Devices Market, by Guidance Modality, 2016 - 2026 (US$ Mn)
7.5.4. Middle East & Africa Breast Biopsy Devices Market, by Region, 2016 – 2026 (US$ Mn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa
Chapter 8. Company Profiles
8.1. Hologic
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Becton, Dickinson and Company
8.3. C.R. Bard, Inc.
8.4. Mammotome (Devicor Medical Products, Inc.)
8.5. Aurora Imaging Technology, Inc.
8.6. Planmed OY
FIG 1. Breast Biopsy Devices Market: Research Methodology
FIG 2. Breast Biopsy Devices: Market Segmentation
FIG 3. Global Breast Biopsy Devices Market, by Biopsy Type, 2017 (US$ Mn)
FIG 4. Global Breast Biopsy Devices Market, by Product, 2017 (US$ Mn)
FIG 5. Global Breast Biopsy Devices Market, by Guidance Modality, 2017 (US$ Mn)
FIG 6. Global Breast Biopsy Devices Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global Breast Biopsy Devices Market, by Key Players, 2017
FIG 9. Global Fine Needle Biopsy Devices Market, 2016-2026(US$ Mn)
FIG 10. Global Core Needle Biopsy (CNB) Devices Market, 2016-2026 (US$ Mn)
FIG 11. Global Vacuum Assisted Breast Biopsy (VABB) Devices Market, 2016-2026 (US$ Mn)
FIG 12. Global Incisional and Excisional Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 13. Global Needle Based Biopsy Guns Market, 2016-2026 (US$ Mn)
FIG 14. Global Biopsy Guidance Systems Market, 2016-2026 (US$ Mn)
FIG 15. Global Biopsy Forceps Market, 2016-2026 (US$ Mn)
FIG 16. Global Biopsy Needles Market, 2016-2026 (US$ Mn)
FIG 17. Global Other Breast Biopsy Products Market, 2016-2026 (US$ Mn)
FIG 18. Global Stereotactic X-ray Guided Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 19. Global Ultrasound Guided Biopsy Market, 2016-2026 (US$ Mn)
FIG 20. Global MRI Guided Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 21. Global Without Imaging Guidance Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 22. U.S. Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 23. Canada Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 24. U.K. Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 25. Germany Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 26. Rest of Europe Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 27. China Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 28. Japan Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 29. Rest of Asia Pacific Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 30. Brazil Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 31. Mexico Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 32. Rest of Latin America Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 33. GCC Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
FIG 34. Rest of Middle East and Africa Breast Biopsy Devices Market, 2016-2026 (US$ Mn)
TABLE 1 Global Breast Biopsy Devices Market Portraiture
TABLE 2 Global Breast Biopsy Devices Market, by Biopsy Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Breast Biopsy Devices Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 4 Global Breast Biopsy Devices Market, by 0047uidance Modality, 2016 – 2026 (US$ Mn)
TABLE 5 Global Breast Biopsy Devices Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America Breast Biopsy Devices Market, by Biopsy Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Breast Biopsy Devices Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 8 North America Breast Biopsy Devices Market, by Guidance Modality, 2016 – 2026 (US$ Mn)
TABLE 9 North America Breast Biopsy Devices Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Breast Biopsy Devices Market, by Biopsy Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe Breast Biopsy Devices Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Breast Biopsy Devices Market, by Guidance Modality, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Breast Biopsy Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific Breast Biopsy Devices Market, by Biopsy Type, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Breast Biopsy Devices Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific Breast Biopsy Devices Market, by Guidance Modality, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific Breast Biopsy Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America Breast Biopsy Devices Market, by Biopsy Type, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America Breast Biopsy Devices Market, by Product, 2016 – 2026 (US$ Mn
TABLE 20 Latin America Breast Biopsy Devices Market, by Guidance Modality, 2016 – 2026 (US$ Mn
TABLE 21 Latin America Breast Biopsy Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa Breast Biopsy Devices Market, by Biopsy Type, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa Breast Biopsy Devices Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa Breast Biopsy Devices Market, by Guidance Modality, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa Breast Biopsy Devices Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 26 Hologic: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 C.R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Mammotome (Devicor Medical Products, Inc.): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Aurora Imaging Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Planmed OY: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Power transmission cables are widely used in transmission and distribution of electricity to various residential and commercial consumers.Power transmission cables are insulated with various materials such as PVC (Poly Vinyl Chloride), XLPE (Polyethylene with cross-links), rubber, impregnated paper and varnished cambric. Global power transmission cables market is projected to register significant growth over the forecast period.Increasing investment in renewable energy across the globe requires installation of new power transmission lines to connect with the existing grid.
A variety of life-threatening & chronic disorders such as hematological diseases, immune deficiencies, genetic diseases, neurological disorders among others are treated with plasma proteins. The different clinical responses of plasma proteins are due to its unique biochemical profile, and variances in production & processing technologies. Recent developments observed in plasma protein therapeutics industry are satisfactory and ground breaking, especially recently approved recombinant protein therapeutics which caters several clinical indications such as autoimmune diseases, cancers, infectious diseases and genetic disorders.
Soil stabilization is a term referred to the process of converting natural soil to build highways, roads etc. Methods employed to change the soil can be physical, chemical or biological through which texture, tensile strength, waste bearing capacity etc.
